Human peripheral blood granulocytes were analyzed for expression of interleukin-6 (IL-6) using reverse-transcriptase polymerase chain reaction (RT-PCR) and in situ hybridization. Neutrophil granulocytes from healthy donors were shown to express variable levels of IL-6. This expression was rapidly down-regulated after the removal of the cells from the circulating blood. In vitro culture of neutrophils abolished IL-6 expression, which could be reactivated by addition of GM-CSF to the culture medium. Constitutive expression of IL-6 was instead demonstrated in eosinophil granulocytes purified from normal donors and from a hy-RANULOCYTES are specialized effectors of antimi-G crobial defenses and inflammation. In addition, these cells can mediate antitumoral activity by different mechanisms, including the production of superoxide and other toxic oxygen metabolites and antibody-dependent cell-mediated cytotoxicity (ADCC).'.' In a previous study, we found that neutrophils were able to inhibit the in vivo growth of a murine colon carcinoma expressing granulocyte colony-stimulating factor (G-CSF) upon retroviral vector-mediated G-CSF gene tran~fer.~.~ In sublethally irradiated mice, tumors were initially formed and then regressed after mice recovered their normal leukocyte count. Regression of an already formed tumor required T cells in addition to neutrophils, thus suggesting a cross-talk between neutrophils and T This possibility is corroborated by reports showing the ability of antigenprimed la-positive neutrophils to induce proliferative response in antigen-primed T lymphocytes,6 and the involvement of neutrophils in priming and effector phase of transplantation immunity to tumors in the rat.6 Neutrophils could produce cytokines with stimulatory activity of the Tcell functions.' Indeed, the activity of neutrophils and eosinophils was mainly documented by showing their ability to produce platelet-activating factor (PAF)' and cytokines such as IL-1, IL-8, tumor necrosis factor a (TNFa), G-CSF, macrophage-CSF (M-CSF), granulocyte-macrophage-CSF (GM-CSF),*-I3 and transforming growth factor a (TGFa), TGFB, IL-1, IL-3, and GM-CSF,I4-l6 respectively.
cytes.17 IL-6 gene expression has not been reported in eosinophils and its expression in neutrophils is controversial because of possible monocyte contamination of neutrophil preparations. We investigated whether IL-6 RNA is detectable in granulocytes either by RT-PCR, to detect low level of RNA, or by in situ hybridization, to confirm morphologically which cells express the gene. Here we present evidence for IL-6 expression in both eosinophils and neutrophils.
MATERIALS AND METHODS
Approval was obtained from the Institutional Review Board for these studies. Volunteers were informed that blood samples were obtained for research purpose, and that their privacy would be protected.
Polymorphonuclear granulocytes (PMN) were isolated from the buffy-coat cells of healthy donors or from heparinized peripheral blood collected by venipuncture from healthy volunteers. Mononucleated cells were isolated by Ficoll-Hypaque density gradient (Pharmacia, Uppsala, Sweden): neutrophils were recovered from the cell pellet by further sedimentation through dextran (2% final concentration). Erythrocytes were removed by hypotonic lysis. Mononucleated cells were enriched in monocytes by adherence to culture dishes for 30 minutes and removal of nonadherent cells by washing with cold phosphate-buffered saline (PBS); adherent cells were gently detached with rubber scrapers. Eosinophils were obtained from healthy donors or from neoplastic patients treated with subcutaneous injections of IL-2 by centrifugation of total leukocytes over hypertonic metrizamide discontinuous gradient, according to Vadas et a1.I8 All cell populations were resuspended in cold Ca2+/Mg2+-free PBS, counted, tested for viability by trypan blue dye exclusion, and slides prepared for morphologic analysis by Wright Giemsa staining, and for in situ hybridization tests. Neutrophils were shown to be more than 98% pure, with a few contaminating eosinophils (mean, 1.2%) or mononucleated cells (mean, 0.8%). The monocyte-enriched cell population contained 38% monocytes with contaminating granulocytes never exceeding I%; eosinophil preparations were between 82% and 96% pure. Cell preparations were resuspended at 2.5 X IO6 cells/mL in complete Dulbecco's modified Eagle medium (DMEM; supplemented with 10% fetal calf serum [FCS] , glutamine, and antibiotics). plated in 24-well flat-bottomed plates, and cultured for I hour at 37°C in a 5% C02 atmosphere. Recombinant human (Hu) GM-CSF, 50 ng/mL, was added immediately or after I hour of culture and further incubated for another hour. All of the reagents used were found to be free of endotoxin. Fresh isolated cells and cells stimulated with GM-CSF were lysed in 4 mol/L guanidinium isothiocyanate for RNA extraction. Total RNA was prepared by cesium Cell purifcation and culture. chloride gradient" and reverse-transcribed using 0.5 pg of oligo-dT primer (Clontech. Palo Alto, CA) and Moloney murine leukemia virus-reverse transcriptase (MMLV-RT RRL. Gaithersburg. MD) for 2 hours at 42°C. cDNA. 2 pL. was used for amplification of (3' -microglobulin (to check for effective cDNA synthesis) or IL-6 using specific primers (Clontech) according to the protocol provided by the manufacturer. After 30 cycles of amplification. 8 of 50 pL of the PCR product was run on a I .570 agarose gel and transferred to nylon filters by alkaline blotting. Semiquantitative PCR was performed for IL-6 according to the method of Dallman et al.'" The densitometric scanning of the &microglobulin-amplified band was used to normalize the cDNA among the samples. Filters were hybridized as described'' with 0.5 to 1.0 X IO6 cpm/mL of "P-labeled probe. which was the 587-bp Cfii I internal fragment obtained from the IL-6 amplified product of human phytohemogglutinin (PHA)-stimulated peripheral blood lymphocytes.
RNA isolation and RT-PCR.
Freshly isolated cells were centrifuged on poly-(L-lysine)-coated slides. fixed in 4% paraformaldehyde ( 10 minutes at 4T). and dehydrated through ethanol solution. The slides were soaked in 0.25% acetic anhydride in 0. I mol/L triethanolamine solution pH 8 for 10 minutes to minimize nonspecific background binding.
A 628-bp cDNA was amplified by PCR from PHA-stimulated peripheral blood lymphocytes and cloned in pGEM-3 vector. Antisense and sense R N A probes were transcribed according to standard proceduresand labeled with 35S-uridine triphosphate. Hybridization was performed at 42"/50"C in a humid chamber for I8 to 20 hours. in 50% formamide. 20 In sitir /yh-idiwion.
RESULTS
RNA from peripheral blood-purified granulocytes was reverse-transcribed and the resulting cDNA amplified with Pzmicroglobulin and IL-6 primers. As a control. we used total RNA as a template in PCR, to exclude DNA contamination, and endonuclease digestion with Tu9 I, Mho I, and Chi I to confirm IL-6 specificity (Fig I) . Southern blots were hybridized with the IL-6 cDNA probe and the hybridization signal was stronger in neutrophil granulocytes from immediately processed blood withdrawals than in neutrophils from donors' buffy-coat cells provided by the blood bank (Fig 2A) . However. IL-6 was inducible in low-expressing samples by a lhour incubation with 50 ng/mL recombinant huGM-CSF (Fig 2A. lanes 6 and 7) . When granulocytes expressing IL-6 were left in DMEM for 1 hour in ice or at 37°C. IL-6 transcript was no longer detectable. but was still inducible by addition of GM-CSF (Fig 2B) . To evaluate the amount of IL-6 transcribed by cells contaminating our preparations. we performed a semiquantitative PCR on cDNA from ( I ) a preparation of more than 98% pure neutrophils with less than 2% contaminating eosinophils and lymphocytes, (2) a mononuclear cell population enriched in monocytes, and (3) eosinophil granulocytes obtained from a normal donor (>82"0 pure) and from a patient with IL-2-induced hypereosinophilia (>968 pure). The results shown in Fig 3 indicate that the low number of contaminating cells of each population examined cannot by itself account for the amount of IL-6 RNA detected. In fact. the eosinophil preparations (lanes 2 and 3) displayed a signal quantitatively similar to that shown by the neutrophil granulocyte preparation (lane I). As expected. the monocyte-enriched population expressed the highest level of IL-6 (Fig 3. lane 4) and the positive signal was already detectable after 20 cycles of amplification: however, both unstimulated neutrophil and eosinophil granulocytes from normal donors (lanes 1 and 2) and the eosinophils of the hypereosinophilic patient (lane 3) also expressed IL-6 (Fig 3) . This suggests that the signal of neutrophils (lane I ) cannot be due to the weak eosinophil contamination.
These results were confirmed by in situ hybridization. IL-6 antisense probe positively hybridized 50% of the neutrophils immediately purified from whole peripheral blood (Fig 4C  through E) . but not the neutrophils isolated from buffy coats ( Fig 4G) . We hypothesized that a rapid down-regulation of IL-6 occurred in neutrophils during the time elapsing between the venipuncture and the slide preparation, which is necessarily longer for blood samples taken from a blood bank:
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No. of cycles therefore, the low mRNA level could remain detectable after PCR amplification (Fig I , lanes 4 and 5) , but not after in situ hybridization (Fig 4G) . Eosinophils were all positively hybridized (Fig 4F) . even when purified from buffy coats ( Fig  4G) .
Both RNAse pretreatment of the slides (not shown) and hybridization with the sense probe (Fig 4A and B) failed to show any positive signals. Neutrophil, but not eosinophil. cell integrity was affected by certain hybridization conditions. eg, hybridization temperature of 50°C. A reduced hybridization temperature (42°C) allowed both the recognition of neutrophils for their nuclear morphology and the hybridization with the IL-6 riboprobe (Fig 4E) without affecting hybridization specificity, because no positive signal was detected with the sense probe (Fig 4B) .
DISCUSSION
Human granulocytes have been considered for a long time as cells with reduced biosynthetic activity but, more recently. it has been shown that PMN are able to produce For personal use only. on October 25, 2017. by guest www.bloodjournal.org From with GM-CSF or TNFa," but constitutive expression of IL- 6 has not yet been reported. has been detected in murine circulating granulocytes by immunohistochemical analysis,25 but the corresponding mRNA was undetectable at the Northern blot assay, while it was evident in the bone marrow myeloid precursors, thus suggesting that circulating PMN were only able to store synthesized in the early stage of their maturation.
Using RT-PCR to increase the sensitivity of mRNA detection, we found IL-6 expression in circulating, unstimulated human granulocytes, both neutrophils and eosinophils, and confirmed this finding by in situ hybridization.
Bazzoni et alZ6 were not able to detect IL-6 transcript by Northern blot in neutrophils stimulated with either lipopolysaccharide or IgG-opsonized yeast, and they argued that IL-6 expression reported by Cicco et alZ2 in GM-CSF-and TNFa-stimulated neutrophils could be due to contaminating monocytes. We used a semiquantitative RT-PCR assay on highly purified cell populations to burst the sensitivity of the detection and minimize the contribution of the contaminating cells to the final amount ofthe amplified product. Our results confirm that peripheral blood granulocytes are able to transcribe IL-6 mRNA constitutively, even though mononuclear cells express this cytokine at higher levels.26-28
In neutrophils, IL-6 expression was rapidly up-modulated by GM-CSF or down-regulated by unknown starvation factor or handling procedures, since differences were found between neutrophils prepared from heparinized peripheral blood immediately after withdrawal and cells purified from buffy coats ofblood bank donors. We postulate that the time lag between venipuncture and cell separation, longer than 1 hour in the case of buffy-coat cells and less than 15 minutes in the other cases, can affect IL-6 expression. However, differences in the anticoagulant used (heparin for peripheral blood of volunteers, citrate/phosphate/ dextrose/adenine in the case of buffy coats from the blood bank) cannot be ruled out.
In eosinophils isolated from subjects with atopy or helmintic infection, IL-6 expression and secretion, as well as its up-regulation by interferon-y, has been documented in vit r~. *~ These investigators were concerned whether circulating eosinophils express IL-6 constitutively, and their data were obtained in activated eosinophils cultured for 24 hours. While confirming IL-6 expression, our results indicate that the mRNA is detectable in freshly isolated eosinophils in both normal individuals and hypereosinophilic patients treated with IL-2.
The role of IL-6 expressed by circulating PMN is currently unknown. The broad spectrum of action of this cytokine includes the ability to "prime" PMN, which enhances superoxide ~ecretion.~' One can speculate that IL-6 expressed by circulating granulocytes could be used for a rapid priming of the other PMN recruited at the same time by a PMN chemotactic factor.
The quantitative dominance of granulocytes in the peripheral blood could compensate for the low amount of IL-6 transcript detected in unstimulated leukocytes and suggests that IL-6 may exert other functions in addition to the acutephase response and inflammation, by participating to the signals governing cell-cell and cell-endothelium cross-talk. Moreover, it has been found that can induce the expression of ICAM-1 in canine myocytes and greatly enhance the CDl8-mediated adhesion of neutrophils to these cells3'; granulocytes could therefore be able to modulate their own capacity to adhere to mesenchymal cells by expressing 
